Literature DB >> 26537319

Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells.

Aurore Fraix1, Marco Blangetti2, Stefano Guglielmo2, Loretta Lazzarato2, Nino Marino1, Venera Cardile3, Adriana C E Graziano3, Ilse Manet4, Roberta Fruttero5, Alberto Gasco2, Salvatore Sortino6.   

Abstract

The design, synthesis, photochemical properties, and biological evaluation of a novel photoactivatable bichromophoric conjugate are reported. The compound 1, [4-(4,4-difluoro-2,6-diiodo-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacen-8-yl)-N-(3-((4-nitro-3-(trifluoromethyl)phenyl)amino)propyl)butanamide] combines a 2,6-diiodo-1,3,5,7-tetramethyl BODIPY derivative as singlet oxygen ((1) O2 ) photosensitizer and 4-nitro-3-(trifluoromethyl)aniline (NOPD) as nitric oxide (NO) photodonor, joined by an alkyl spacer. These two chromogenic units absorb in distinct regions of the visible spectrum, and their individual photochemical properties are conserved in the molecular conjugate. Irradiation of the bichromophoric conjugate with green light afforded (1) O2 in high quantum yields, whereas (1) O2 production was negligible with the use of blue light; under this latter condition, NO was released. Photogeneration of NO and cytotoxic (1) O2 can therefore be regulated by appropriately tuning the excitation light wavelength and intensity. Tested on melanoma cancer cells, this resulted in amplified photomortality relative to that of a structurally correlated model compound 2 [4-(4,4-difluoro-2,6-diiodo-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacen-8-yl)-N-(3-(p-tolylamino)propyl)butanamide] deprived of the NO-release capacity. The cellular uptake of 1, evaluated by confocal fluorescence microscopy, showed that the product is localized in the cytoplasm.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bimodal therapy; light; nitric oxide; photodynamic therapy; radicals

Mesh:

Substances:

Year:  2015        PMID: 26537319     DOI: 10.1002/cmdc.201500396

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  4 in total

1.  Phytocomplex of a Standardized Extract from Red Orange (Citrus sinensis L. Osbeck) against Photoaging.

Authors:  Barbara Tomasello; Giuseppe Antonio Malfa; Rosaria Acquaviva; Alfonsina La Mantia; Claudia Di Giacomo
Journal:  Cells       Date:  2022-04-25       Impact factor: 7.666

2.  Diaminorhodamine and Light-Activatable NO Donors: Photorelease Quantification and Potential Pitfalls.

Authors:  Tatyana Yu Dranova; Aleksey Yu Vorobev; Eduard V Pisarev; Alexander E Moskalensky
Journal:  J Fluoresc       Date:  2020-11-06       Impact factor: 2.217

3.  A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy.

Authors:  Ya Wang; Xiaoyu Huang; Yunyun Tang; Jianhua Zou; Peng Wang; Yewei Zhang; Weili Si; Wei Huang; Xiaochen Dong
Journal:  Chem Sci       Date:  2018-08-29       Impact factor: 9.825

Review 4.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.